Analyst Reco. Ipsen

Equities

IPN

FR0010259150

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 19:55:00 18/02/2026 +03			5-day change	1st Jan Change
157.30 ^EUR	+1.09%		+13.33%	+32.18%

02-13	Genfit to Receive $20 Million Milestone Payment Linked to Sales of Ipsen's Iqirvo	MT
02-13	Ipsen Remains in the Green with UBS Support

Analyst Reco.

02-13	Ipsen Remains in the Green with UBS Support
02-12	Ipsen: Markets applaud strong finish to 2025 and better-than-expected 2026 outlook
01-14	Ipsen, Top Gainer on the SBF 120 and SRD at Wednesday, January 14, 2026 Close
01-14	Ipsen and EMS-Chemie Shine on the Stock Market, Vistry and Pearson Struggle
01-08	UBS No Longer Recommends Buying Ipsen, Citing Full Valuation
11-26	BNP Paribas Downgrades Ipsen to Underperform, Trims PT	MT
11-18	AlphaValue/Baader Europe Ups Ipsen's EPS Forecasts After Q3 Beat, 'Substantial' FY25 Outlook Upgrade	MT
11-17	Ipsen raises 2025 outlook after stronger Somatuline
11-07	Ipsen to Present Positive Data on PBC at AASLD 2025
22/10/25	Ipsen: Robust Q3 fuels a guidance upgrade
13/10/25	Ipsen: UBS reiterates buy recommendation
12/09/25	Sadif Investment Analytics Upgrades Ipsen to Hold	MT
13/08/25	RBC Keeps Ipsen at Outperform Amid Upcoming Potential Catalysts	MT
12/08/25	Ipsen: RBC still a buyer, TP EUR148
31/07/25	Ipsen: Performance across key offerings fell short of expectations, unsettling investors
04/06/25	Deutsche Bank Restarts Ipsen Coverage with Buy Rating	MT
04/06/25	Ipsen: Deutsche Bank resumes coverage as a buyer
06/05/25	RBC Lifts Ipsen Price Target on Iqirvo Q1 Growth, New Indication Opportunity	MT
06/05/25	Ipsen: RBC raises target price
17/04/25	AlphaValue/Baader Europe Keeps Buy Rating on Ipsen After Q1 Results	MT
16/04/25	Ipsen: In-line Q1; 2025 guidance unchanged
02/04/25	Ipsen: Deutsche Bank upgrades to buy
28/03/25	Ipsen: Ipsen remains a compelling Smaller Pharma investment
13/02/25	Ipsen: Q4 beat led by Somatuline
11/02/25	Ipsen: Oddo BHF raises its target price on the stock

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

Ipsen: Markets applaud strong finish to 2025 and better-than-expected 2026 outlook

February 12, 2026 at 05:32 pm